MARKET

CTEV

CTEV

Claritev Corp
NYSE
26.43
+2.43
+10.13%
Opening 15:12 11/10 EST
OPEN
24.28
PREV CLOSE
24.00
HIGH
26.83
LOW
23.19
VOLUME
627.95K
TURNOVER
--
52 WEEK HIGH
72.67
52 WEEK LOW
11.50
MARKET CAP
447.92M
P/E (TTM)
-1.5542
1D
5D
1M
3M
1Y
5Y
1D
Claritev price target raised to $47 from $43 at Canaccord
TipRanks · 3h ago
Claritev (CTEV) Receives a Buy from Guggenheim
TipRanks · 8h ago
Canaccord Genuity Sticks to Their Buy Rating for Claritev (CTEV)
TipRanks · 8h ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Claritev (CTEV), Aldeyra Therapeutics (ALDX) and Argenx Se (ARGX)
TipRanks · 9h ago
Claritev Corp (CTEV) Q3 2026 Earnings Call Transcript
The Motley Fool · 23h ago
Claritev Q3 2026 Earnings Call Transcript
Benzinga · 1d ago
Claritev Corporation Reports Q3 2026 Revenues of $268.3 million and Updates full-year 2026 guidance
NASDAQ · 1d ago
Claritev Raises FY2026 Sales Guidance from $1.000B-$1.020B to $1.038B-$1.043B vs $1.014B Est
Benzinga · 1d ago
More
About CTEV
Claritev Corp, formerly MultiPlan Corporation, is a healthcare technology, data and insights company. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The Company uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. It uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. It provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.

Webull offers Claritev Corp stock information, including NYSE: CTEV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTEV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTEV stock methods without spending real money on the virtual paper trading platform.